Our department is currently offering a wide variety of molecular diagnostic services mainly for inherited diseases. The aim is to provide the clinician with qualitative and quantitative data regarding the aetiology and pathogenesis of a disease. This valuable data assists clinicians with diagnosis, patient stratification, drug prescription, and prognosis.
MGDC is currently offering diagnostic services for the following diseases:
CYP21A2 gene mutation detection
Sweat Test
MEFV gene mutation detection
HFE gene mutation detection
RET proto-oncogene mutation detection (multiple endocrine neoplasia type 2A/2B)
Connexin 26/30 (GJB2/6) gene mutation detection
Cystinuria - Family Linkage Analysis and SLC3A1 gene mutation detection.